Securities code: 300942 securities abbreviation: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) Announcement No.: 2022-013 Shenzhen Bioeasy Biotechnology Co.Ltd(300942)
Announcement on the use of some temporarily idle raised funds for cash management
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) (hereinafter referred to as “the company”) held the 10th meeting of the second board of directors and the 10th meeting of the second board of supervisors on February 25, 2022, deliberated and adopted the proposal on using some temporarily idle raised funds for cash management, and resolved that under the condition of ensuring that the normal construction of investment projects with raised funds and the safety of raised funds are not affected, It is proposed to use part of the temporarily idle raised funds with a total amount of no more than RMB 100 million for cash management for the purchase of investment products with good liquidity, high safety, principal guaranteed and a maximum period of no more than 12 months. The service life is valid within 12 months from the date of deliberation and approval by the board of directors, and can be recycled and used within the above-mentioned amount and period. At the same time, the general manager of the company is authorized to make specific decisions on the investment within the above validity period and limit, sign relevant documents, and the financial department of the company is responsible for specific implementation. The details are hereby announced as follows:
1、 Basic information of raised funds
With the approval of registration of Shenzhen Bioeasy Biotechnology Co.Ltd(300942) initial public offering (zjxk [2021] No. 87) issued by the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”), the company publicly issued 40860000 RMB common shares (A shares) to the public at an issue price of 5.31 yuan / share, and the total amount of funds raised was 216966600.00 yuan, After deducting various issuance expenses (excluding value-added tax) of RMB 41613251.89, the net amount of funds actually raised is RMB 175353348.11.
Lixin Certified Public Accountants (special general partnership) verified the availability of the raised funds of the company on February 4, 2021 and issued the capital verification report (xksbz [2021] No. zl10004). After verification, all the above raised funds have been in place. The company has stored the raised funds in a special account and signed the tripartite supervision agreement on raised funds with the sponsor and the commercial bank storing the raised funds.
2、 Use of raised funds and temporary idleness
According to the investment projects of raised funds disclosed in the prospectus of Shenzhen Bioeasy Biotechnology Co.Ltd(300942) initial public offering and listing on GEM, the funds raised by the company’s initial public offering will be invested in the following projects after deducting the issuance expenses:
Unit: Yuan
No. project name total investment amount of raised funds investment amount
1 food safety rapid detection product production line construction project 213467100.00 175353348.11
Total 213467100.00 175353348.11
According to the actual construction progress of the project invested by the raised funds, some of the raised funds will be idle in the short term. On the premise of not affecting the normal construction of investment projects with raised funds and the daily operation of the company, the company will reasonably use idle raised funds for cash management to improve the use efficiency of raised funds.
3、 The use of some idle raised funds for cash management this time
(I) investment purpose
Given that the implementation and construction of raised investment projects requires a certain period, in order to improve the use efficiency of funds, the company plans to use the temporarily idle raised funds for cash management without affecting the normal construction and implementation of raised investment projects and the safety of raised funds, so as to better maintain and increase the value of the company’s cash and protect the interests of the company’s shareholders.
(II) investment varieties
The company will strictly control risks according to relevant regulations and strictly evaluate the products invested by temporarily idle raised funds, which must meet the following conditions:
(1) Products with high security such as structured deposits and certificates of deposit;
(2) Good liquidity, which shall not affect the normal operation of the investment plan of the raised funds;
(3) The product life shall not exceed 12 months.
The above investment products shall not be pledged, and the special settlement account for products shall not deposit non raised funds or be used for other purposes; If a special settlement account for products is opened or cancelled, the company will timely report to Shenzhen stock exchange for filing and announcement.
(III) investment amount and term
The company plans to use part of the temporarily idle raised funds of no more than RMB 100 million for cash management. The service life is valid within 12 months from the date of deliberation and approval by the board of directors. Within the above limit and term, it can be used circularly.
(IV) implementation mode
After the deliberation and approval of the board of directors, the company authorizes the general manager to make specific decisions on the investment within the above use limit and sign relevant documents, which shall be implemented by the financial department of the company.
(V) information disclosure
The company will do a good job of relevant information disclosure in accordance with the relevant provisions of Shenzhen Stock Exchange and other regulatory agencies.
4、 Investment risk and risk control measures
(I) investment risk
1. Although the financial products have been strictly evaluated and the investment products to be selected belong to low-risk investment varieties, the financial market is greatly affected by the macro-economy, and it is not excluded that the investment is affected by market fluctuations. 2. The company will intervene timely and appropriately according to the economic situation and changes in the financial market, so the actual income of short-term investment is unpredictable.
3. Operation and monitoring risks of relevant staff.
(II) for investment risks, the company plans to take the following measures:
1. The company will strictly abide by the principle of prudent investment and choose low-risk investment varieties. It shall not be used for other securities investment, nor for the purchase of bank financial products with stocks, their derivatives and unsecured bonds as the investment object.
2. The company will timely analyze and track the investment direction of financial products. During the financial management of the above financial products, the company will maintain close contact with relevant financial institutions, timely track the operation of financial funds and strengthen risk control
3. The internal audit department of the company shall conduct daily supervision on the use and custody of financial funds, and regularly audit and verify the use of financial funds.
4. The board of supervisors and independent directors of the company have the right to supervise and inspect the use of funds, and can hire professional institutions to audit when necessary.
5. The company will timely disclose relevant information in accordance with the relevant provisions of Shenzhen Stock Exchange. 5、 Impact on the daily operation of the company
The company plans to use part of the temporarily idle raised funds for cash management on the premise of ensuring the normal construction of the company’s investment projects with raised funds and the safety of the raised funds. There is no situation of changing the purpose of the raised funds in a disguised manner and damaging the interests of shareholders.
Through the timely cash management of the temporarily idle raised funds, we can obtain a certain investment income, improve the use efficiency of the company’s funds and seek more investment returns for the company and shareholders.
6、 Review procedures and special opinions for implementation
On February 25, 2022, the company held the 10th meeting of the second board of directors and the 10th meeting of the second board of supervisors, and deliberated and adopted the proposal on using some temporarily idle raised funds for cash management. The independent directors of the company expressed their independent opinions on the proposal. The recommendation institution has issued an agreed verification opinion.
(I) opinions of the board of directors
It is agreed that the company will use part of the temporarily idle raised funds with a total amount of no more than RMB 100 million for cash management to purchase investment products with good liquidity, high safety, principal guaranteed and a maximum period of no more than 12 months without affecting the normal construction of the company’s investment projects with raised funds and the safety of the raised funds, The term of use is valid within 12 months from the date of deliberation and approval by the board of directors, and can be recycled and rolled within the above limit and term; It is agreed to authorize the general manager of the company to make specific decisions on the investment within the above validity period and limit and sign relevant documents, which shall be implemented by the financial department of the company.
(II) opinions of the board of supervisors
At present, the company is in good operation and stable financial condition. The company uses part of the temporarily idle raised funds with a total amount of no more than RMB 100 million for cash management, and there is no situation affecting the normal construction of the investment projects with raised funds and the safety of the raised funds. Reasonable use of idle raised funds for cash management can increase income and obtain better returns for the company and shareholders, which is in line with the interests of the company, does not harm the interests of the company and all shareholders, and complies with the relevant provisions of relevant laws, regulations and normative documents. Therefore, all supervisors unanimously agreed to the proposal.
(III) opinions of independent directors
The company’s use of some temporarily idle raised funds for cash management this time complies with the requirements of normative documents such as the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, the articles of association, the management system of raised funds and other rules and regulations, It is in line with the interests of the company and all shareholders, and there is no situation of changing the purpose of the raised funds in a disguised form and damaging the interests of the company and all shareholders, especially small and medium-sized shareholders. Therefore, we agree that the company will use some temporarily idle raised funds for cash management.
(IV) verification opinions of the recommendation institution
After verification, the recommendation institution believes that:
The company’s use of temporary idle raising of no more than RMB 100 million for cash management has been deliberated and approved at the 10th meeting of the second board of directors and the 10th meeting of the second board of supervisors, and the independent directors have expressed their independent opinions with explicit consent and fulfilled the necessary deliberation procedures.
The above matters comply with the relevant provisions of the Shenzhen Stock Exchange GEM Listing Rules and the Shenzhen Stock Exchange listed companies self regulatory guidelines No. 2 – standardized operation of GEM listed companies. It does not involve the change or disguised change of the purpose of the raised funds, does not affect the normal construction of the investment projects with the raised funds, and does not damage the interests of the company and all shareholders. The recommendation institution has no objection to the above-mentioned company’s use of some temporarily idle raised funds for cash management.
7、 Documents for future reference
1. Resolutions of the 10th meeting of the second board of directors;
2. Independent opinions of independent directors on matters related to the 10th meeting of the second board of directors;
3. Resolutions of the 10th meeting of the second board of supervisors;
4. Dongxing Securities Corporation Limited(601198) verification opinions on Shenzhen Bioeasy Biotechnology Co.Ltd(300942) using some idle raised funds for cash management.
It is hereby announced.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) board of directors February 26, 2022
